301060 兰卫医学
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-2.312-7.36834.02914.6279.187
总资产报酬率 ROA (%)-1.435-4.20521.09711.3977.690
投入资产回报率 ROIC (%)-1.921-6.18830.49014.1529.114

边际利润分析
销售毛利率 (%)20.99720.80142.63638.23232.292
营业利润率 (%)-4.611-8.11222.60617.93514.413
息税前利润/营业总收入 (%)-4.524-8.94621.72017.94313.052
净利润/营业总收入 (%)-4.029-9.65817.59914.71110.861

收益指标分析
经营活动净收益/利润总额(%)-33.6277.078124.74599.158107.815
价值变动净收益/利润总额(%)-6.9951.3830.2673.1984.566
营业外收支净额/利润总额(%)5.88211.367-4.957-0.288-9.955

偿债能力分析
流动比率 (X)3.4532.8272.3974.2795.747
速动比率 (X)2.9322.3812.1133.9415.072
资产负债率 (%)28.34133.70439.34322.1170.152
带息债务/全部投入资本 (%)14.05416.07211.8621.3600.995
股东权益/带息债务 (%)598.356511.272721.9207,018.7429,903.254
股东权益/负债合计 (%)228.803176.847139.966336.060545.334
利息保障倍数 (X)-12.058-43.468119.390303.208-229.626

营运能力分析
应收账款周转天数 (天)200.854347.656129.355132.613140.101
存货周转天数 (天)87.018104.41340.42246.96068.879